Jump to main content
Jump to site search
Access to RSC content Close the message box

Continue to access RSC content when you are not at your institution. Follow our step-by-step guide.


Issue 28, 2019
Previous Article Next Article

The cubane paradigm in bioactive molecule discovery: further scope, limitations and the cyclooctatetraene complement

Author affiliations

Abstract

The cubane phenyl ring bioisostere paradigm was further explored in an extensive study covering a wide range of pharmaceutical and agrochemical templates, which included antibiotics (cefaclor, penicillin G) and antihistamine (diphenhydramine), a smooth muscle relaxant (alverine), an anaesthetic (ketamine), an agrochemical instecticide (triflumuron), an antiparasitic (benznidazole) and an anticancer agent (tamibarotene). This investigation highlights the scope and limitations of incorporating cubane into bioactive molecule discovery, both in terms of synthetic compatibility and physical property matching. Cubane maintained bioisosterism in the case of the Chagas disease antiparasitic benznidazole, although it was less active in the case of the anticancer agent (tamibarotenne). Application of the cyclooctatetraene (COT) (bio)motif complement was found to optimize benznidazole relative to the benzene parent, and augmented anticancer activity relative to the cubane analogue in the case of tamibarotene. Like all bioisosteres, scaffolds and biomotifs, however, there are limitations (e.g. synthetic implementation), and these have been specifically highlighted herein using failed examples. A summary of all templates prepared to date by our group that were biologically evaluated strongly supports the concept that cubane is a valuable tool in bioactive molecule discovery and COT is a viable complement.

Graphical abstract: The cubane paradigm in bioactive molecule discovery: further scope, limitations and the cyclooctatetraene complement

Back to tab navigation

Supplementary files

Article information


Submitted
28 May 2019
Accepted
13 Jun 2019
First published
26 Jun 2019

Org. Biomol. Chem., 2019,17, 6790-6798
Article type
Paper

The cubane paradigm in bioactive molecule discovery: further scope, limitations and the cyclooctatetraene complement

S. D. Houston, T. Fahrenhorst-Jones, H. Xing, B. A. Chalmers, M. L. Sykes, J. E. Stok, C. Farfan Soto, J. M. Burns, P. V. Bernhardt, J. J. De Voss, G. M. Boyle, M. T. Smith, J. Tsanaktsidis, G. P. Savage, V. M. Avery and C. M. Williams, Org. Biomol. Chem., 2019, 17, 6790
DOI: 10.1039/C9OB01238A

Social activity

Search articles by author

Spotlight

Advertisements